Aim: To assess the burden of respiratory syncytial virus-associated disease in older adults (RSV OA), ≥50 years old, in World Health Organization region countries in Africa, the Americas (except for Canada and the USA), Eastern Mediterranean, Europe (except for European Union countries and the UK), South-East Asia, and Western Pacific (except for Australia, China, Japan, New Zealand, and South Korea).